Navigating the Crossroads of Transfusion and Revascularization Strategies in Myocardial Infarction: Is There a Turning Point?
- PMID: 40270233
- DOI: 10.1161/CIRCINTERVENTIONS.125.015422
Navigating the Crossroads of Transfusion and Revascularization Strategies in Myocardial Infarction: Is There a Turning Point?
Keywords: Editorials; anemia; blood transfusion; myocardial infarction; percutaneous coronary intervention.
Conflict of interest statement
Dr Kunkel reports personal consulting honoraria from Abbott, Johnson & Johnson, and Medtronic. Dr Kandzari reports institutional research/grant support from Biotronik, Boston Scientific, Medtronic, Orbus Neich and Teleflex; and personal consulting honoraria from Abbott, Boston Scientific, Medtronic, Ablative Solutions, DeepQure and GoldenLeaf Medical.
Comment on
-
Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial.Circ Cardiovasc Interv. 2025 May;18(5):e015249. doi: 10.1161/CIRCINTERVENTIONS.125.015249. Epub 2025 Mar 30. Circ Cardiovasc Interv. 2025. PMID: 40159118 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources